GWP.L Regulatory News (GWP)

17 Jan 2007 16:11

GW Pharmaceuticals PLC17 January 2007 GW Pharmaceuticals PLC ("GW") In conformity with the Transparency Directive's transitional provision 6, GWhereby provides notification of the following information: GW's issued capital consists of 120,096,335 ordinary shares of 0.1p each withvoting rights. Therefore, the total number of voting rights in GW is120,096,335. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, GW under the FSA's Disclosure andTransparency Rules. For further information, please contact: GW Pharmaceuticals PLC +44 (0)1980 557 000Jonathan Laughton, Company Secretary This information is provided by RNS The company news service from the London Stock Exchange